For example, a nomogram based on the baseline CA125 level and other clinical factors was developed to predict the 3-year recurrence risk in patients with epithelial ovarian cancer who achieved clinical complete remission after cytoreductive surgery and chemotherapy [4]. Here, MUC16 is linked to ovarian carcinoma.